91 related articles for article (PubMed ID: 12960347)
1. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor.
Gripentrog JM; Kantele KP; Jesaitis AJ; Miettinen HM
J Immunol; 2003 Sep; 171(6):3187-93. PubMed ID: 12960347
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis.
Gripentrog JM; Jesaitis AJ; Miettinen HM
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):399-407. PubMed ID: 11085933
[TBL] [Abstract][Full Text] [Related]
3. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
4. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
[TBL] [Abstract][Full Text] [Related]
5. Normal cell surface expression and selective loss of functions resulting from Phe110 to Ser and Cys126 to Trp substitutions in the formyl peptide receptor.
Nanamori M; He R; Sang H; Ye RD
Immunol Invest; 2004 May; 33(2):193-212. PubMed ID: 15195697
[TBL] [Abstract][Full Text] [Related]
6. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of the NPXXY motif in formyl peptide receptor signaling.
He R; Browning DD; Ye RD
J Immunol; 2001 Mar; 166(6):4099-105. PubMed ID: 11238659
[TBL] [Abstract][Full Text] [Related]
8. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
Graham TE; Prossnitz ER; Dorin RI
J Biol Chem; 2002 Mar; 277(13):10876-82. PubMed ID: 11751935
[TBL] [Abstract][Full Text] [Related]
9. Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin.
Miettinen HM; Gripentrog JM; Jesaitis AJ
J Cell Sci; 1998 Jul; 111 ( Pt 14)():1921-8. PubMed ID: 9645940
[TBL] [Abstract][Full Text] [Related]
10. Agonist-dependent phosphorylation of the formyl peptide receptor is regulated by the membrane proximal region of the cytoplasmic tail.
Suvorova ES; Gripentrog JM; Jesaitis AJ; Miettinen HM
Biochim Biophys Acta; 2009 Feb; 1793(2):406-17. PubMed ID: 18952127
[TBL] [Abstract][Full Text] [Related]
11. N-formyl peptide receptors cluster in an active raft-associated state prior to phosphorylation.
Xue M; Vines CM; Buranda T; Cimino DF; Bennett TA; Prossnitz ER
J Biol Chem; 2004 Oct; 279(43):45175-84. PubMed ID: 15302864
[TBL] [Abstract][Full Text] [Related]
12. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
[TBL] [Abstract][Full Text] [Related]
13. Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.
Gripentrog JM; Mills JS; Saari GJ; Miettinen HM
Immunogenetics; 2008 Feb; 60(2):83-93. PubMed ID: 18253729
[TBL] [Abstract][Full Text] [Related]
14. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
15. Ligand-independent CXCR2 dimerization.
Trettel F; Di Bartolomeo S; Lauro C; Catalano M; Ciotti MT; Limatola C
J Biol Chem; 2003 Oct; 278(42):40980-8. PubMed ID: 12888558
[TBL] [Abstract][Full Text] [Related]
16. Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation.
Toy-Miou-Leong M; Cortes CL; Beaudet A; Rostène W; Forgez P
J Biol Chem; 2004 Mar; 279(13):12636-46. PubMed ID: 14699144
[TBL] [Abstract][Full Text] [Related]
17. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of formyl peptide receptor signaling by peptide ligands.
Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
[TBL] [Abstract][Full Text] [Related]
19. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
20. Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation.
Vines CM; Xue M; Maestas DC; Cimino DF; Prossnitz ER
J Immunol; 2002 Dec; 169(12):6760-6. PubMed ID: 12471107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
